INTRODUCTION
Adequate blood supply to tissues is an absolute requirement for survival from the time that embryos reach a body length of approx. 2 mm; furthermore, perfusion demands change throughout development and with many physiological adaptations in adults. These changing demands are accommodated by angiogenesis or vessel deletion in the microcirculation and by structural remodelling of pre-existing conduit vessels. Although peripheral tissues can self-regulate local angiogenesis through, for example, control of VEGF (vascular endothelial growth factor) production by HIF-1 (hypoxia-inducible factor-1) [1, 2] , upstream conduit arteries are not exposed to these tissue releasates. Instead, restructuring of arteries is often driven by a direct sensitivity of vascular cells to physical forces. Accordingly, increases or decreases in the shear stresses imposed by blood flow on endothelium elicit remodelling that increases or decreases arterial diameter respectively. In addition to this adaptive remodelling in response to altered blood flow rate, arteries also display relative wall thickening when blood pressure is chronically elevated and remodel lengthwise when axial forces on arteries change [2, 3] . The latter are important when tissues to which arteries are attached grow or regress during development or undergo pathological atrophy or hypertrophy, consider superficial coronary vessels of the hypertrophied heart or vessels intrinsic to the pre-and post-partum uterus.
Force-induced remodelling comprises virtually all conceivable modes of tissue reorganization, including proliferation, re-orientation, migration and apoptosis of mural cells, as well as synthesis, degradation and reorganization of extracellular matrix. It is indeed intriguing that medial smooth muscle cells are capable, within limits, of selectively delivering daughter cells and matrix in the circumferential, radial and lengthwise directions in response to shear stress, circumferential wall tension due to blood pressure and to lengthwise loads imposed by surrounding tissues.
This review examines two modes of force-dependent arterial remodelling that have particular clinical significance. Relative wall thickening appropriately adapts the artery wall to the profound developmental increases in blood pressure that occur in utero [4] and again at parturition [2, 5] ; however, it also elevates flow resistance in smaller arteries and thereby contributes to progression of hypertension in adults. Similarly, inward remodelling with blood flow reduction is important developmentally, but it can seriously exacerbate hypoperfusion due to arterial occlusive disease. In both cases, an emerging concept is that narrowing can occur in two phases, an early vasoconstriction that is followed by a chronic wall restructuring. Our early work demonstrated such a two-phase response for inward remodelling in response to blood flow reduction [6] , and recent intriguing data indicate that remodelling may be a non-specific response to persistent vasoconstriction that may contribute importantly to the progression of hypertension [7, 8] .
ARTERIAL REMODELLING AND THE PROGRESSION OF HYPERTENSION
Essential hypertension in humans is characterized by abnormal arterial wall structure, as reflected by an increased wall thickness to lumen ratio. Taken alone, these data could reflect a primary vascular developmental anomaly; however, their recapitulation in multiple experimental models of induced hypertension [9] suggests remodelling of the artery wall during progression of the disorder.
Arterial remodelling that accompanies hypertension involves wall hypertrophy in large arteries and eutrophic inward remodelling in resistance vessels. The reduced diameter in the latter impacts on total peripheral resistance and, therefore, on the progression of hypertension. The most straightforward explanation of eutrophic inward remodelling (narrowing with no change in wall mass) is that constriction has been entrenched ( Figure 1 ). There is evidence that such constriction results from vasoconstrictor production secondary to renal dysfunction, dysregulation of other neuron-endocrine inputs or endothelial dysfunction. A role for vasoconstrictor inputs is supported by observations that many agents that can (and do) influence the pathogenesis in the hypertension are vasoregulators, including AngII (angiotensin II), ET-1 (endothelin-1) and NO [10] . However, these agents are pleiotropic and can also contribute to tissue remodelling by influencing cell proliferation, apoptosis and matrix reorganization.
A central, but controversial, hypothesis in hypertension research has been that narrowing of resistance arteries becomes incorporated into a positive feedback loop that promotes progression of hypertension. This 'vascular amplifier' model of the progression of hypertension has been updated to include recognition that neurohumoral contributors to hypertension can influence arterial remodelling, and that driving normal flows through narrowed vessels will yield shear stress-related modulation of the remodelling process [9] . The rarefaction of resistance arteries that also occurs with hypertension [10] will add to this shear load, as normal tissue perfusion is forced through fewer vessels. Ultimately, a new steady state can be achieved where normal tissue perfusion is sustained at elevated pressures by structural, rather than vasoconstrictor, mechanisms ( Figure 1 ).
REMODELLING IN RESPONSE TO PATHOLOGICALLY REDUCED PERFUSION
The capacity of physical forces related to blood flow (shear stresses) to induce vascular remodelling has been recognized by embryologists for over a century [11] and its continued influence on arterial development throughout the post-natal period is now proven [6, 12, 13 ]. An important study by Kamiya and Togawa [14] showed that adult arteries retain a capacity to remodel in response to altered blood flow rates. We subsequently demonstrated that the endothelial sensitivity to shear stress drives flow-dependent remodelling [15] , and that remodelling comprised early vasoregulation followed by entrenchment of the change in diameter by structural remodelling [6] . Much subsequent work has demonstrated the importance of this remodelling to chronic adaptations of the mature vasculature. Accordingly, physiological increases or decreases in tissue perfusion during exercise training, pregnancy/parturition and reproductive cycles have proven to be potent stimuli for remodelling that ultimately produce corresponding changes in vessel lumen sizes [16] [17] [18] . However, pathologies often subvert physiological responses, and the consequences of 'adaptive' narrowing of arteries during pathological hypoperfusion of tissues can be dire.
Atherosclerosis, thrombosis and thrombo-embolism can severely limit tissue perfusion. If acute events are not lethal, then the responses of the vasculature that carries compromised blood flow over the ensuing days to weeks are important to long-term outcome. These responses can be quite different for arterial tissue at sites of lesions compared with healthy arterial segments at upstream or downstream locations. Atherosclerotic
Figure 1 Model of remodelling processes that contribute to vascular dysfunction
Inward remodelling after hypoperfusion (arterial occlusive disorders) comprises vasoconstriction that is followed by structural entrenchment. Similar mechanisms may contribute to the eutrophic remodelling of resistance arteries that characterizes hypertension. With hypoperfusion, vessel narrowing normalizes shear stress and then chronic remodelling processes (matrix cross-linking/turnover and cellular remodelling that normalizes cell length) contribute to sustained subnormal tissue blood flow. In essential hypertension, inward eutrophic remodelling, which may comprise constriction due to multiple stimuli followed by structural entrenchment, contributes to the elevation in total peripheral resistance that is the hallmark of the disorder. Since perfusion rates are normal in essential hypertension, the narrowed diameters and rarefaction of resistance vessels cause elevation of shear stress, which provides negative feedback to limit narrowing. EDHF, endothelium-derived hyperpolarizing factor. lesion sites often display 'compensatory enlargement', which involves a circumferential expansion of the media that limits or prevents reduction in luminal diameter until lesions become quite large, i.e. until lesion cross-sectional area approaches that of the lumen [19] . This expansive remodelling has been attributed to elevation of shear stress as the lesion first starts to encroach upon the lumen. (As flow accelerates through the modest constriction, shear is elevated in proportion to the inverse cube of vessel diameter.)
Compensatory enlargement is clearly advantageous, as it limits the consequences of early disease. However, compensatory enlargement fails as lesion cross-sectional area exceeds approximately two thirds of lumen area. When lesion growth then encroaches on the lumen and compromises blood flow, upstream and downstream segments of the artery experience decreased shear. Shearrelated arterial narrowing then exacerbates the pathology. Accordingly vasoconstrictor responses and their entrenchment by structural remodelling during hypoperfusion parallel those seen with hypertension, but with quite different implications for vascular dysfunction (Figure 1 ).
Recent findings, particularly those of Berk and coworkers [20] , have added a new perspective concerning arterial remodelling in response to reduced blood flow. They found that severely reduced blood flow rate elicits migration of smooth muscle cells to the intima and their proliferation and elaboration of matrix at this site. Importantly, this neointimal growth was accompanied by increased external vessel diameter in a setting in which shear is much reduced. This finding raises the interesting possibility that this neointimal growth includes significant elaboration of tissues in the circumferential direction that expands external diameter. Assessments of 'residual stress' in these artery walls, which reveal non-uniformities in tensile loading across the media [21] , could prove informative in understanding how loads in the artery wall are redistributed during this remodelling.
THE TWO PHASES OF INWARD ARTERIAL REMODELLING
As indicated above, both hypertension and hypoperfusion elicit inward remodelling of arterial structure that is consistent with the concept that constriction is followed by entrenchment through tissue reorganization. Indeed, this is a common, perhaps universal, paradigm for reducing tissue dimensions, e.g. myometrial smooth muscle contraction is critical to post-partum involution of the uterus and myofibroblast contraction initiates retraction of scar tissues. Conversely, the only alteration to mechanical loads imposed on arterial tissue that is not normalized by remodelling is reduction in lengthwise stretch (40-60 %), a failure that we attributed to the circumferential orientation of medial smooth muscle cells, which precludes contraction-induced reductions in vessel length [22] . Accordingly, contraction of tissues followed by remodelling may be commonplace; however, it has been poorly studied.
Vasoconstriction
Vasoconstrictors are proven participants in the pathogenesis of hypertension. A central role for the renin-angiotensin system is well-established, although endothelial dysfunction, compromised NO production and hyperresponsive to agonists of vascular smooth muscle are also involved (see Feihl et al. [10] for review). Myogenic vasoconstriction, i.e. smooth muscle contraction that is directly stimulated by elevated pressure and wall stretch, can augment primary constrictor responses. Myogenic constriction, an important contributor to physiological autoregulation of blood flow, is greatest in smaller arteries and arterioles, and the potent narrowing of these vessels followed by rapid entrenchment may contribute to the eutrophic nature of remodelling seen in smaller arteries. (It has been argued that the potent myogenic constriction in resistance vessels prevents tensile wall stress from increasing and it is for this reason that small vessels do not hypertrophy in chronic hypertension. This may be true, but at the subcellular level, constriction only off-loads cellular structures that are coupled in parallel with the contractile apparatus. Important force sensors in smooth muscle, e.g. integrins [23] , are probably series-coupled to contractile filaments; therefore, they experience increased loading when the cells contract, regardless of what happens to bulk wall stress.)
Contraction also initiates inward remodelling after blood flow reduction, because narrowing can initially be reversed by vasodilators [6] , but the vasoactive agents that regulate this process are still under investigation. NO is a proven shear-dependent vasoregulator; indeed, constitutive NO production is probably driven by shear forces. Consequently, flow reductions lead to NO withdrawal and the balance of vasoregulation shifts towards constriction. Shear-regulated NO production is first due to activation of eNOS (endothelial NO synthase) that has been attributed to phosphorylation of eNOS by Akt [24, 25] , downstream of shear-induced PI3K (phosphoinositide 3-kinase) activation, although an Aktindependent mechanism has been identified [26] . In the longer term, shear further regulates NO production by modulating eNOS expression, apparently through sheardependent activation of NF-κB (nuclear factor κB) [27] . Additional mediators (prostanoids and endotheliumderived hyperpolarizing factor) can complement the actions of NO, which explains the persistence of flow-related vasodilation in eNOS −/− mice [28, 29] ; nonetheless, these mice fail to display inward remodelling after flow reduction. This finding, plus others discussed below, indicate that the contribution of NO to arterial remodelling goes beyond vasoregulation.
There is also evidence that initiation of vessel narrowing after flow reduction is due to endothelium-derived constrictor release and not simply the withdrawal of vasodilator activity. Accordingly, inward remodelling is ablated by endothelial denudation, but it is restored as endothelium re-grows. This behaviour cannot be reconciled with a model in which withdrawal of an endotheliumderived vasodilator fully explains inward remodelling. The simplest alternative explanation is that release of an endothelium-derived vasoconstrictor is enhanced when shear stress decreases. ET-1 is an attractive candidate, because ET-1 mRNA expression in cultures of endothelial cells is up-regulated in low compared with high shear stress conditions [30] [31] [32] [33] , and we have evidence supporting a role for this agonist [34] .
Entrenchment
After reduced perfusion, and possibly during the pathogenesis of hypertension, persistent vasoconstriction is followed by entrenchment of the smaller vessel diameter via restructuring of arterial wall components. Entrenchment after flow reduction takes days to weeks in large arteries [6] , but evidence discussed below indicates that constrictor responses may be entrenched much more rapidly in small arteries and arterioles. These remodelling processes have important implications for therapeutic interventions that target the pathologies that underlie them, and recent work has revealed intriguing new insights into their regulation.
Martinez-Lemus et al. [35] found that noradrenaline (norepinephrine)-induced constriction of skeletal muscle arterioles was partially irreversible after only 4 h. Intriguingly, over 50 % of mural cells had returned to resting cell lengths over this time, even though constriction of vessel diameter was fully sustained. The active restoration of normal cell length probably contributes to entrenchment of reduced diameter. But how do cells lengthen while maintaining contractile activity? And how is concomitant reorganization of cell-cell and cell-matrix Available evidence indicates that tTG is important in entrenching reduced diameter after blood flow reduction and with constriction due to ET-1. Possible mechanisms include cross-linking matrix constituents and enhancing matrix, e.g. fibronectin (FN), coupling to integrins. tTG can also enhance contraction by interacting with Rho, and Rho GTPase-mediated regulation of actin assembly may contribute to the restoration of resting cell length in arterioles that remain persistently constricted (see text).
adhesion complexes achieved while the cells continue to transmit tensile loads at these sites? Changes in cell shape that are not due to modulation of contractile tone are usually due to actin assembly, under the control of Rho GTPases, which also control reorganization of cell adhesion complexes [36] . These findings indicate an intriguing interplay between Rho regulation of cell elongation due to actin assembly and the control that Rho exercises over smooth muscle cell contraction (Figure 2) . RhoA, via its target Rho-kinase (ROCK), inhibits myosin phosphatase and thus increases Ca 2+ sensitivity of the contractile apparatus in smooth muscle cells [37, 38] ; furthermore, Rho proteins regulate eNOS phosphorylation and expression [39, 40] .
Regardless of changes that are intrinsic to smooth muscle cells, structural alterations to extracellular matrix are required for permanent alterations in diameter of most arteries, because extracellular matrix bears much of pressure-related wall tension. Turnover of extracellular matrix may be involved, but this is generally a very slow process. (For example, the half-life of elastin in healthy human tissues is decades [41, 42] ). Recent intriguing evidence indicates that tTG (tissue transglutaminase) participates in remodelling and this enzyme may well affect matrix properties (Figure 2) . Bakker et al. [7] showed that entrenchment of ET-1-or low-flow-induced constriction was inhibitable with tTG antagonists and that exogenous, or up-regulation of endogenous, tTG enhanced remodelling. Also, the same group showed that tTG knockout mice exhibit delayed inward remodelling following flow reduction in mesenteric arterioles, and they provided evidence that macrophage-derived factor XIII, another transglutaminase, may contribute to the delayed response [8] . tTG is constitutively expressed in vascular cells [43] ; however, expression may be modulated during flow-induced remodelling responses. Accordingly, functional response elements in the promoter region of the gene respond to known shear-dependent modulators, including TGF-β (transforming growth factor-β) and NF-κB signalling.
Transglutaminases are Ca 2+ -dependent enzymes with diverse intracellular and extracellular activities, and tTG has been implicated previously in vascular remodelling during angiogenesis [44] . With respect to extracellular matrix, it can induce highly stable cross-linking of collagens, fibronectin, vitronectin and other matrix constituents, which probably contribute to chronic entrenchment of inward remodelling. Older data indicating that entrenchment of vessel narrowing after flow reduction occurs without normalizing medial histology (e.g. elastic lamellae remain permanently tortuous [6] ) are more readily reconciled with a cross-linking mechanisms than with matrix turnover.
Additional functions of tTG besides cross-linking may participate in arterial remodelling (Figure 2) . Extracellular tTG can act as a co-receptor for fibronectin by associating with β-integrins to enhance cell adhesion and cell motility [45, 46] , which may contribute to the elongation of contracted smooth muscle cells that was observed by Martinez-Lemus et al. [35] . The tTG that interacts with integrins and fibronectin can be hydrolysed by MMP (matrix metalloproteinase)-2, which is activated during flow-related remodelling. Furthermore, intracellular tTG can translocate to the nucleus to regulate gene transcription or induce chromatic modifications, thus potentially affecting expression of genes that mediate tissue remodelling responses [47] . Also, apoptotic cell death participates in inward remodelling responses following blood flow reduction [48] , and the increase in [Ca 2+ ] i (intracellular Ca 2+ concentration) during apoptosis activates tTG. Extensive tTG-mediated cross-linking of cellular proteins is important in stabilizing cell structure and limiting the release of pro-inflammatory substances until apoptotic bodies are phagocytosed. Finally, intracellular tTG could augment smooth muscle cell contraction, because increased cytoplasmic Ca 2+ levels activate tTG which can then enhance RhoA/ROCK-2 kinase binding and ROCK-2 activation [49, 50] .
Recent results indicate an additional mechanism by which RhoA links to chronic remodelling processes. MMPs denature type 1 collagen, and Chapados and coworkers [51] have found that contact with this processed collagen activates RhoA/ROCK-2, which then induces elaboration of tenascin-C, a component of a 'provisional matrix' laid down by smooth muscle cells during tissue remodelling. The authors provide further evidence that this RhoA-dependent matrix elaboration participates in arterial remodelling during the pathogenesis of pulmonary hypertension. It will be interesting to see how matrix turnover, matrix cross-linking and provisional matrix synthesis are integrated to ultimately entrench structural changes in remodelling arteries.
Role of NO in chronic remodelling
Null mutation of the eNOS gene ablates inward remodelling of hypoperfused mouse carotid arteries, and it also produces a curious thickening of the arterial media that was secondary to medial smooth muscle cell proliferation [52] . Importantly, eNOS is activated by shear when it is freed from an inhibitory association with caveolin-1 [24] , and the effect of eNOS knockout was phenocopied in caveolin-1 −/− mice, whereas endothelium-specific reconstitution of caveolin-1 by expression of a transgene rescued the phenotype [53] .
The simplest explanation for the failure of arteries of eNOS −/− mice to narrow after flow reduction is that early constriction is due to withdrawal of constitutive NOinduced dilation. However, it is important that the in vivo studies cited above assessed remodelling at day 14, after structural remodelling is completed; therefore, the role of NO prior to entrenchment of the response is unproven. Furthermore, NO is clearly doing more than regulating vessel tone, given the paradoxical wall thickening that flow reduction produces in its absence. In this context, the antiproliferative effects of NO on smooth muscle cells are noteworthy [54] . Signalling of cGMP, the second messenger of NO, probably mediates most of the antiproliferative actions of NO in late G 1 -phase of the cell cycle [55, 56] . In addition, cGMP-independent actions, e.g. inhibition of ribonucleotide reductase, occur in S-phase [56] . Withdrawal of NO could therefore bias remodelling responses toward hyperproliferation. Alternatively, attenuation of NO expression or activity could consequently lead to up-regulation of mitogens such as ET-1.
NO also can influence matrix turnover by regulating MMP function. Up-regulation of MMP-2 mRNA and increased activity of MMP-2 occur in both outward and inward flow-induced remodelling [57, 58] , and NO participates in MMP-2 and MMP-9 activation with increased blood flow [59] . Finally, tTG provides another avenue through which NO might regulate remodelling. NO is a potent inhibitor of tTG activity through Ca 2+ -sensitive nitrosylation of multiple cysteine residues [60, 61] . Suppression of NO production by reductions in shear stress should activate tTG to first activate constriction, through RhoA/ROCK-2 signalling, and then entrench the diameter reduction by cross-linking matrix.
SEVERE HYPOPERFUSION AND INTIMAL PROLIFERATION
Low shear stresses enhance intimal proliferation that is initiated by injury and graft implantation [62] [63] [64] [65] [66] [67] [68] [69] . In addition, newer results indicate that extreme reductions in blood flow (90 %+), in the absence of other stimuli, can elicit substantial proliferation of smooth muscle cells and matrix in the intima, at least in some arteries. The first indication of such flow-induced neointimal formation came from studies of complete flow cessation [70] , and subsequent work identified smooth muscle as the resident cell type in these lesions [71] [72] [73] . The role of endothelial cell necrosis and thrombosis in responses to vessel ligation has proven contentious [70] [71] [72] ; however, more recent work has shown that severe flow reduction, rather than cessation, can induce intimal proliferation while maintaining a viable endothelium [74] . These findings are important, because they provide an additional mechanism by which responses to low shear stress can contribute to the progression of arterial occlusive disorders.
An intriguing feature of remodelling after extreme flow reduction is that medial narrowing was not observed, despite unquestionable proof that such narrowing always accompanies more modest flow reduction. How can this be so? It is possible that extreme flow reductions do not elicit the same endothelium-dependent vasoregulatory responses as more modest flow reductions. Alternatively, early intimal accumulation of 'synthetic' (non-contractile) smooth muscle cells and matrix may block diffusion of endothelial releasates to the media or it may physically constrain medial narrowing. In any event the capacity of extreme flow reduction to promote intimal proliferative disorders has important implications for the pathogenesis of restenosis and for the sequelae to acute vascular (e.g. coronary) events.
FUTURE THERAPEUTIC DIRECTIONS
Inward vascular remodelling in the context of pathologically reduced tissue perfusion is almost certainly deleterious; therefore, strategies to suppress this phenomenon have therapeutic potential. Currently, targets of such therapy are limited by present knowledge of mechanisms regulating the process. If ET-1 proves to be an important initiator, then both receptor blockers and ECE-1 (ET-1-converting enzyme-1) inhibitors may provide avenues for therapeutic intervention. Inhibitors of MMPs are also of interest, given the role of MMPs in inward remodelling; furthermore, the capacity of MMP-2 to activate big ET-1 [75] may add to the attractiveness of MMP inhibition. Evidence that tTG contributes to entrenchment of inward remodelling suggest potential new directions as well. Recent findings that statins suppress inward remodelling in renovascular disease while down-regulating tTG expression [76] may signal novel benefits of these multifunctional drugs.
CONCLUSIONS
Arterial remodelling in response to altered haemodynamics is central to arterial development and to the adaptation of the mature circulation to chronic changes in cardiovascular function. However, the great majority of vascular disorders create clinical manifestations because they compromise haemodynamic function. In these pathological settings, 'adaptive' remodelling to perturbed haemodynamics may sometimes be beneficial, or it can be subverted to promote progression of the disease state. Controlling remodelling processes may therefore provide avenues for treatment of cardiovascular disease. Recent evidence indicates that structural remodelling can comprise a coordinated integration of physiological adjustments of vasomotor tone with elaboration, reorganization and cross-linking of wall tissues. In some cases, the same signalling pathways regulate both processes. A current challenge is to understand fully these signals and their targets and then to manipulate them in ways that re-direct remodelling processes to prevent or induce regression of unfavourable structural responses to vascular dysfunction.
